ADVERTISEMENT

Differences In MHC Molecules In Regions With High Pathogen Diversity

The immune system is our body’s defense against infectious microorganisms. Some of the most important players of the immune system are a group of proteins called MHC molecules. By binding to short fragments of molecules derived from pathogens, they play a crucial role in triggering an immune response. The genes encoding our MHC molecules vary greatly from person to person, and this variation has been linked to several diseases. For example, those carrying certain variants of MHC molecules might be suffering from autoimmune diseases or be more susceptible to certain pathogens.

Intriguingly, MHC molecules also differ in their geographical distributions, with some of them being prevalent in Europe while others are more prevalent in Southeast Asia. Why is this so? An interdisciplinary team of scientists, Máté Manczinger, Balázs Papp, and Csaba Pál from the Biological Research Centre of the Hungarian Academy of Sciences and collaborators in Szeged, Budapest, and Plön, proposed a new hypothesis to explain this variation.

ADVERTISEMENT

In a nutshell, MHC molecules are known to be either specialists or generalists. The former recognize only a few types of pathogens, while the latter recognize many of them and, hence, can activate the immune response against a wide range of viruses and bacteria. According to their hypothesis, generalist MHC molecules are favored in geographical regions with a high diversity of pathogens (e.g. tropical regions). In contrast, in regions of low pathogen richness, such as in Northern Europe, specialists work well enough to sustain a proper immune defense. By analyzing publicly available data, the researchers showed that generalist MHC molecules are indeed more frequent in geographical regions of high pathogen diversity. This finding suggests that exposure to pathogens was a key driving force in the evolution of the human immune system and it shaped the prevalence of different MHC gene variants across the globe.

But why don’t all of us carry generalist MHC molecules? Researchers speculate that these molecules come at a cost: generalist MHC molecules also likely recognize more non-harmful molecules and proteins made by our own body, potentially leading to allergic and autoimmune diseases. Additionally, recognizing only a limited repertoire of molecules of only a few pathogens – which is the case for specialists – could lead to a more specific and effective immune response and might be beneficial under certain conditions. Thus, the prevalence of a particular MHC variant depends on its benefits and drawbacks, which in turn depends on the richness of pathogens in the environment.

The study will likely encourage researchers to revisit some of the key issues in immunology and genomics. For example, the genes encoding MHC molecules are the most variable regions in the human genome. Thus, different individuals of human populations carry thousands of different MHC variants. What shapes this huge genetic variation? The authors speculate that the geographic distribution of generalist MHC molecules could have a substantial impact on the genetic diversity of MHC genes, which is an interesting area of future research. In a similar vein, the diversity of MHC-encoding genes is associated with olfaction-based mate choice in human and other animals. Accordingly, it will be interesting to see whether generalist and specialist MHC molecules play a role in mating success.

Finally, genetic variation within particular MHC genes influences vaccine efficacy, rejection rates of transplanted organs, and anticancer immunity. Generalist and specialist MHC molecules could have a hitherto unrecognized impact on these immune processes. Clearly, a better understanding of the causes and consequences of genetic variation in MHC molecules will also help clinicians to customize treatment to an individual’s genetic makeup.

ADVERTISEMENT

These findings are described in the article entitled Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations, recently published in the journal PLOS Biology. Csaba Pál and Máté Manczinger contributed to this research and article as PI and postdoc, respectively at the Institute of Biochemistry, Biological Research Centre.

Comments

READ THIS NEXT

What Mitochondrial Cristae Are Telling Us About HIV-associated Neurological Disorder

Mitochondria are small intracellular organelles with a diameter about the size of a few microns. They serve crucial functions for […]

Heme-Specific Antibodies

A healthy adult human has about 2-3×1013 red blood cells (RBC) with a hemoglobin (Hb) content of about 3.108 molecules/RBC, […]

Florida Panhandle Map

The Florida panhandle map is chock-full of beautiful beaches, charming little towns, and cool salty breezes. Because of its shape, […]

Motives For Playing Pokémon Go Can Predict Healthy And Problematic Use

Published by Ágnes Zsila and Gábor Orosz ELTE Eötvös Loránd University and Stanford University, Department of Psychology These findings are described […]

Did You Know Math Can Help Us Learn How Diseases Work?

New research shows how computer-based math models can communicate with neurons to study neurodegenerative diseases. Brain diseases such as epilepsy […]

Record Low Voltage Losses In Efficient Cascade Organic Solar Cells

The sun is a limitless energy source, and photovoltaics is the most commonly used technology for converting solar energy into […]

Idiopathic Normal Pressure Hydrocephalus Should Be Increasingly Recognized: Results From A Population-Based Prevalence Study

This study is the first prospective, population-based prevalence study particularly designed for idiopathic normal pressure hydrocephalus (iNPH). The finding of […]

Science Trends is a popular source of science news and education around the world. We cover everything from solar power cell technology to climate change to cancer research. We help hundreds of thousands of people every month learn about the world we live in and the latest scientific breakthroughs. Want to know more?